pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 36 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
telitacicept
telitacicept [INN]
Primary Sjogren's Syndrome
$VORVor Biopharma Inc.
1 catalysts
Phase 3
(atisnolerbart + bremzalerbart + umesolerbart)
Birch Pollen Allergy
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
(efgartigimod alfa + hyaluronidase (human recombinant))
Vyvgart Hytrulo ((efgartigimod alfa + hyaluronidase (human recombinant)-qvfc))
Idiopathic Inflammatory Myopathy (IIM)
$ARGXARGENX SE
← prev
page 1 of 2
next →
131
Pain89
Neurology1
0 catalysts
Phase 3
Descartes-08
Myasthenia Gravis
$RNACCartesian Therapeutics, Inc.
0 catalysts
Phase 3
GC-5107D
Primary Humoral Immune Deficiencies
GC Biopharma Corp
0 catalysts
Phase 3
PHVS-416
deucrictibant
Angioedema
Pharvaris NV
0 catalysts
Phase 3
Pollinex Quattro Grass
Pollinex
Allergic Rhino-Conjunctivitis
Allergy Therapeutics Plc
0 catalysts
Phase 3
TAK-881
Primary Immune Deficiency (PID)
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
anifrolumab
Saphnelo (anifrolumab-fnia)
Idiopathic Inflammatory Myopathy (IIM)
Interferon alpha/beta receptor 1
$AZNASTRAZENECA PLC
0 catalysts
Phase 3
belimumab
Benlysta (belimumab)
Systemic Sclerosis (Scleroderma)
Tumor necrosis factor ligand superfamily member 13B
$GSKGSK plc
0 catalysts
Phase 3
cemdisiran + pozelimab
Myasthenia Gravis
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
cenerimod
Systemic Lupus Erythematosus
Sphingosine 1-phosphate receptor 1
Idorsia Pharmaceutical Ltd
0 catalysts
Phase 3
cetoquagene parvec
Xerostomia
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 3
civorebrutinib
civorebrutinib [INN]
Neuromyelitis Optica (Devic's Syndrome)
SinoMab Bioscience Ltd
0 catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCXQuince Therapeutics, Inc.
0 catalysts
Phase 3
envudeucitinib
Plaque Psoriasis (Psoriasis Vulgaris)
$ALMSALUMIS INC.
0 catalysts
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIBBIOGEN INC.
0 catalysts
Phase 3
freneslerbart + mevonlerbart
Cat Allergy
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVSNOVARTIS AG
0 catalysts
Phase 3
imeroprubart
Rheumatoid Arthritis
$IMVTImmunovant, Inc.
0 catalysts
Phase 3
litifilimab
Cutaneous Lupus Erythematosus
C-type lectin domain family 4 member C
$BIIBBIOGEN INC.
0 catalysts
Phase 3
lonvoguran
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$NTLAIntellia Therapeutics, Inc.
0 catalysts
Phase 3
mivocabtagene autoleucel
mivocabtagene autoleucel [INN]
Myasthenia Gravis
$KYTXKyverna Therapeutics, Inc.
0 catalysts
Phase 3
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTLAutolus Therapeutics plc
0 catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 3
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
ADARx Pharmaceuticals Inc
0 catalysts
Phase 3
piclidenoson
Plaque Psoriasis (Psoriasis Vulgaris)
Adenosine receptor A3
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Phase 3
pozelimab
Veopoz (pozelimab-bbfg)
Myasthenia Gravis
Complement C5
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts